Figure 3. Best objective responses in tumor size for patients in the four treatment groups. GC-f: Full-dose gemcitabine plus cisplatin (n=33); GCr: reduced-dose gemcitabine plus cisplatin (n=10); G-Car-f: full-dose gemcitabine plus carboplatin (n=24); G-Car-r: reduced-dose gemcitabine plus carboplatin (n=11); CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.
